Diabetes over the past few years has emerged as a public health issue for many countries worldwide. As per the CDC, diabetes is the seventh leading cause of death in the United States and is a significant cause for kidney failure, lower-limb amputations, and adult blindness. If it remains undiagnosed and untreated, it increases the chance of getting many other health complications in later life. To deal with the increasing prevalence of diabetes, companies such as Novo Nordisk, Sanofi, Mylan, Bayer Pharmaceuticals, Boehringer Ingelheim, Eli Lilly and Company, AstraZeneca, and others are actively engaged in therapeutics development.
For more detailed information, visit: Diabetes Types and Treatment Options